A Shared-Value Model for Enhancing Diabetes Care in South Africa

By Rene Pretorius

April 4, 2025

Summary

In a world where diabetes management demands both innovation and integration, DiaCision is at the forefront, using AI-driven insights to improve outcomes and reshape the way care is delivered. As we look for transformative models that go beyond traditional approaches, the article “Improving Diabetes Care in South Africa Through a Shared-Value Model” offers an important case study.

This piece reviews a program by Discovery Health, launched in 2021, that aims to enhance diabetes care in South Africa through a shared-value approach. By focusing on improving hemoglobin A1c testing rates, glycemic control, and disease stability, the program has demonstrated measurable success over three years. Notably, it has also contributed to reduced hospital admissions and healthcare costs. In the broader context of advancing diabetes care, this model presents a compelling example of how aligning patient outcomes with system-wide value can lead to scalable, sustainable impact.

Key Insights

  • Shared-Value Model: The program incentivizes medical practitioners to improve diabetes care, leading to better patient outcomes.
  • Glycemic Control and Stability: HbA1c testing rates, glycemic control, and disease stability improved notably.
  • Economic Benefits: Hospital admissions and healthcare costs decreased, suggesting long-term savings.

Background Context

Diabetes is a major global health challenge. The WHO highlights its rising prevalence and the need for effective management. In South Africa, healthcare access varies. Shared-value programs can help bridge gaps in diabetes care in South Africa. The WHO stresses cost-effective interventions that prioritize patient outcomes, aligning with shared-value models.

Implications

This shared-value model has significant implications:

  • Healthcare Cost Reduction: Better diabetes management reduces admissions and costs.
  • Improved Patient Outcomes: Enhanced glycemic control and stability reduce complications and improve quality of life.
  • Scalability and Adaptability: Such programs can inspire similar initiatives elsewhere, aiding broader healthcare reform.

The content highlights innovative healthcare models’ role in improving patient outcomes. Insights from value-based care discussions suggest these models are key to better health outcomes and cost control. For more details, see the original article here.

Reference url

Recent Posts

2025 China Drug Catalog Boosts Access with 114 New Drugs and Innovative Solutions

By HEOR Staff Writer

December 9, 2025

Expansion of Coverage in the 2025 National Basic Medical Insurance Drug Catalog In this update we highlight updates and implications of the 2025 National Basic Medical Insurance Drug Catalog in China's ...
Advancements in Continuous Glucose Monitoring for Type 2 Diabetes Management

By HEOR Staff Writer

November 27, 2025

Advancements in CGM for Type 2 Diabetes Management A recent JAMA Insights article, explores the integration of continuous glucose monitoring as a complementary tool to traditional hemoglobin A1c (HbA1c) an...
Eloralintide Obesity Treatment: Phase 2 Trial Reveals Significant Weight Loss Potential

By HEOR Staff Writer

November 7, 2025

Are you wondering about the latest eloralintide obesity treatment options? Eloralintide, a selective amylin receptor agonist, has shown promising results in managing obesity. In a recent phase 2 trial, it led to significant weight loss of up to 20% over 48 weeks in adults with obesity or overweig...